menu
    • menu

    Company profile for Beijing Avistone Pharmaceuticals Biotechnology

    NEW Drugs in Dev: 5
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avistone is a dedicated oncology company with a focus on developing innovative therapies to address the significant unmet medical needs of patients globally. The company boasts an extensive pipeline that includes two clinical-stage drug candidates and several ongoing programs in the pre-clinical development stage. Avistone's lead asset, PLB1001, is a small-molecule inhibitor targeting MET tyrosine kinase activity, particularly...
    Avistone is a dedicated oncology company with a focus on developing innovative therapies to address the significant unmet medical needs of patients globally. The company boasts an extensive pipeline that includes two clinical-stage drug candidates and several ongoing programs in the pre-clinical development stage. Avistone's lead asset, PLB1001, is a small-molecule inhibitor targeting MET tyrosine kinase activity, particularly addressing aberrant activity associated with METexon14 skipping genetic alterations in NSCLC tumors and other solid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Beijing Avistone Pharmaceuticals BiotechnologyChina Flag
    Country
    Country
    China
    Address
    Address
    Lize Middle 2nd Road, Chaoyang District, Beijing
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://en.avistonebio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/avistone-biotechnology-co-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avistone Reports Positive Results for Vebreltinib plus Andamertin
    Avistone Reports Positive Results for Vebreltinib plus Andamertin

    31 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250531731865/en/Avistone-Announces-Encouraging-Results-for-Vebreltinib-plus-Andamertinib-PLB1004-in-EGFR-mutated-NSCLC-with-MET-Amplification-or-Overexpression-at-ASCO-Annual-Meeting-2025

    BUSINESSWIRE
    31 May 2025
    Share Share
    Avistone Reveals Preclinical Results for ANS03 at AACR 2025
    Avistone Reveals Preclinical Results for ANS03 at AACR 2025

    15 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250415613561/en/Avistone-Announces-Preclinical-Results-for-ANS03-a-Novel-Type-II-ROS1NTRK-Inhibitor-in-Overcoming-Clinically-Relevant-ROS1NTRK-Resistance-Mutations-at-AACR-Annual-Meeting-2025

    BUSINESSWIRE
    15 Apr 2025
    Share Share
    Avistone Announces Updates on ANS03
    Avistone Announces Updates on ANS03

    04 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241204521875/en

    BUSINESSWIRE
    04 Dec 2024
    Share Share
    Avistone Announces Updates on ANS014004
    Avistone Announces Updates on ANS014004

    04 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241004946427/en

    BUSINESSWIRE
    04 Oct 2024
    Share Share
    Avistone Presents NSCLC Combo Study Results At WCLC 2024
    Avistone Presents NSCLC Combo Study Results At WCLC 2024

    10 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240910500605/en

    BUSINESSWIRE
    10 Sep 2024
    Share Share
    Avistone: Announces ASCO 2024 Data From Two Sponsored Clinical Programs
    Avistone: Announces ASCO 2024 Data From Two Sponsored Clinical Programs

    04 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240604496164/en

    BUSINESSWIRE
    04 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search